Skip to main content
LobbyMap

Pfizer Inc

Pharmaceutical & Health Products · Lobbying Client

B
Influence Score
74/100
High Influence
$51.0M
Total Lobby Spend
8
Policy Issues
22
Lobbyists
9
Revolving Door

Pfizer Inc reported $51.0 million in federal lobbying expenditures as disclosed in Senate LDA filings. The organization's lobbying activity spans 8 policy areas, with primary focus on Health Issues, Pharmacy, Medical/Disease Research. This data is drawn from quarterly disclosure reports filed with the Secretary of the Senate under the Lobbying Disclosure Act of 1995.

Annual Lobbying Spend

Policy Issues

Health IssuesPharmacyMedical/Disease ResearchCopyright/Patent/TrademarkTaxationTradeBudget/AppropriationsGovernment Issues

Government Entities Contacted

US Senate
Dept of Justice
Federal Communications Commission
Federal Trade Commission
Dept of Education
US House of Representatives
Dept of Energy
Office of Management & Budget
Dept of Commerce
Dept of Agriculture

Recent Filings

PeriodRegistrantIssuesLobbyistsAmount
2020 Jan-MarCovington & Burling LLP
TAXGOV
1$1.5M
2020 Apr-JunHolland & Knight LLP
BUDGOVTAX+1
3$1.8M
2020 Jul-SepBrownstein Hyatt LLP
MEDPHAHCR
3$1.9M
2020 Oct-DecSquire Patton Boggs LLP
CPTMED
2$1.5M
2021 Jan-MarAkin Gump LLP
MEDHCR
3$2.1M
2021 Apr-JunSquire Patton Boggs LLP
PHACPT
3$2.4M
2021 Jul-SepHolland & Knight LLP
TAXHCRPHA+2
2$2.1M
2021 Oct-DecBGR Group LLP
GOVBUDTRD+2
2$2.5M